WBSCR22 confers oxaliplatin resistance in human colorectal cancer
Dongmei Yan(National Health and Family Planning Commission), Xiaoju Wang(Shanxi Agricultural University)
Cited by 49
Related Papers
Polycomb group proteins EZH2 and EED directly regulate androgen receptor in advanced prostate cancer
|International Journal of Cancer|2019|64
CDK12 loss drives prostate cancer progression, transcription-replication conflicts, and synthetic lethality with paralog CDK13
|Cell Reports Medicine|2024|28
Knockdown of Merm1/Wbscr22 attenuates sensitivity of H460 non-small cell lung cancer cells to SN-38 and 5-FU without alteration to p53 expression levels
|Molecular Medicine Reports|2014|7
Defining CDK12 as a tumor suppressor and therapeutic target in mouse models of tubo-ovarian high-grade serous carcinoma
|Proceedings of the National Academy of Sciences|2025|6
<i>CDK12</i> Loss Promotes Prostate Cancer Development While Exposing Vulnerabilities to Paralog-Based Synthetic Lethality
|bioRxiv (Cold Spring Harbor Laboratory)|2024|1